100,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
50 °P sammeln
  • Broschiertes Buch

Nearly every type of cancer passes through a precancer phase, during which it cannot metastasize or invade other tissues. While medicine is not always successful in treating or curing advanced stages of cancers, recent advances in our understanding of carcinogenesis have helped us to develop strategies to prevent, diagnose, and treat many cancers at the precancer stage. Research in this field is escalating rapidly as the evidence increasingly shows that the number of annual cancer deaths could be drastically reduced through the effective treatment and cure of precancer lesions. This book…mehr

Produktbeschreibung
Nearly every type of cancer passes through a precancer phase, during which it cannot metastasize or invade other tissues. While medicine is not always successful in treating or curing advanced stages of cancers, recent advances in our understanding of carcinogenesis have helped us to develop strategies to prevent, diagnose, and treat many cancers at the precancer stage. Research in this field is escalating rapidly as the evidence increasingly shows that the number of annual cancer deaths could be drastically reduced through the effective treatment and cure of precancer lesions. This book begins by explaining why it has been so difficult to cure cancers, followed by a review of precancer biology, with descriptions of the most common precancer lesions. The final chapters provide practical socio-political and medical goals for precancer treatment, including discussions of the economics and politics of treating precancers.
Autorenporträt
Jules Berman received his bachelor's degrees in Mathematics and Earth and Planetary Sciences from Massachusetts Institute of Technology, his Ph.D. from Temple University, and his M.D. from the University of Miami. He received post-doctoral training in the Laboratory of Experimental Pathology in the National Cancer Institute, at NIH. He received residency training at the George Washington University Medical Center and is board certified in anatomic pathology and in cytopathology. He served as the chief of anatomic pathology at the VA Hospital in Baltimore where he held adjunct appointments at Johns Hopkins Medical Center and the University of Maryland Medical Center. From 1998 to 2005 he was program director for Pathology Informatics in the Cancer Diagnosis Program at the National Cancer Institute. Jules Berman has first-authored more than 100 publications. He is now a free-lance author and the past President of the Association for Pathology Informatics.